U.S. Department of Health and Human Services (HHS)

Rule Changes

Promoted leucovorin for autism; FDA approval did not match its claims

In September 2025, White House officials told parents of autistic children that a cheap, generic drug called leucovorin might improve their children's speech and behavior. Prescriptions surged 71% in the following months, pharmacies ran dry, and the Food and Drug Administration (FDA) allowed emergency imports from Canada and Spain. On March 10, 2026, the FDA approved leucovorin — but only for a genetic condition so rare that fewer than 50 cases have ever been identified worldwide, not for autism.

Updated 7 days ago

Rule Changes

Led by Secretary Robert F. Kennedy Jr.

Jay Bhattacharya co-authored the Great Barrington Declaration in October 2020, publicly opposing the Centers for Disease Control and Prevention's pandemic response policies. Five years later, he now controls both the CDC and the National Institutes of Health—the two largest federal public health agencies—making him the most powerful health official in America outside the cabinet.

Updated Feb 18

Rule Changes

Driving enforcement effort through declarations, investigations, and proposed rules

Lurie Children's Hospital opened the Midwest's first pediatric gender identity clinic in 2013. Thirteen years later, it announced it will no longer prescribe gender-affirming medications to new patients under 18—days after HHS General Counsel Mike Stuart referred the hospital for federal investigation. Lurie joins at least 40 hospital systems that have paused or ended pediatric gender services since January 2025, including Rady Children's Health—California's largest pediatric healthcare system—which announced on January 23, 2026, it will stop all gender-affirming medical interventions on February 6. On February 3, California Attorney General Rob Bonta sued Rady for violating legally binding merger conditions that required the hospital to maintain gender-affirming care through 2034.

Updated Feb 6

Force in Play

Froze $185M in Minnesota child care funding

On January 5, 2026, Governor Tim Walz became the highest-profile political casualty of Minnesota's welfare fraud crisis, announcing he would drop his bid for a third term. The stunning reversal came just two days before a contentious January 7 House Oversight Committee hearing where Republican state lawmakers testified that Walz and Attorney General Keith Ellison ignored rampant fraud and silenced whistleblowers. Within 24 hours of that hearing, the Trump administration dramatically escalated its response: on January 6, HHS froze $10 billion in child care and family assistance funding to five Democratic states—California, Colorado, Illinois, Minnesota, and New York—citing fraud concerns but providing no evidence of wrongdoing outside Minnesota. A coalition of the five states sued immediately, and on January 9, U.S. District Judge Arun Subramanian granted a temporary restraining order blocking the freeze for 14 days. Hours later, Agriculture Secretary Brooke Rollins announced USDA would suspend an additional $129 million in federal awards to Minnesota, prompting Ellison to vow 'I'll see you in court.'

Updated Jan 10

Rule Changes

Provided scientific/medical recommendation and is tasked with expanded research models

Trump’s executive order instructing DOJ to fast-track marijuana’s move to Schedule III immediately triggered a familiar split-screen: public health and industry groups cheered the potential research and tax impacts, while House Republicans organized opposition, urging Trump to keep marijuana in Schedule I.

Updated Dec 18, 2025

Rule Changes

Provided scientific/medical evaluation and scheduling recommendation to DEA

4-CMC is one of those modern drug-market products built for speed: cheap, tweakable chemistry that can be sold as a “new” stimulant the moment the old one gets banned. On December 17, 2025, the U.S. finally snapped the trap shut—DEA’s Schedule I controls for 4-CMC took effect nationwide.

Updated Dec 17, 2025